SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients
Clinical trial NCT03716596 · TERMINATED
Trial details
- NCT number
- NCT03716596
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2019-10-22
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.